Palantir (NYSE:PLTR) and Ginkgo Bioworks (NYSE:DNA) are not chasing the same opportunity. One is a high-expectation AI software leader tied to government adoption. The other is a beaten-down biology infrastructure bet. That gap creates the real investor question: where does the biological firewall create the most value?
Stock prices used were the market prices of June 18, 2026. The video was published on June 27, 2026. On the date of publication, Rick Orford did not have (either directly or indirectly) positions in any of the securities mentioned in this video.
